Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm Fall > What Chemo Drugs DO > Flashcards

What Chemo Drugs DO Flashcards

1
Q

Bevacizumab: what it targets

A
  • Active against isoforms of VEGF

- Prevents activation and promotion of angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bevacizumab: adverse effects

A
  • GI bleeding
  • CNS hemorrhage
  • Vaginal bleeding
  • HTN
  • Bleeding episodes
  • Thrombotic events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sunitinib/ Sorafenib: what it targets

A
  • inhibits VEGFR-2 and platelet derived growth factor receptor
  • Suni used for kidney CA, GI stromal tumor and pancreatic neuroendocrine tumors
  • Sora used for advanced kidney, liver, thyroid CA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sunitinib/Sorafenib: adverse effects

A
  • CHF with sunitinib

- Hand-foot syndrome with sorafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lapatinib: what it targets

A
  • inhibits BOTH intracellular kinase domains of EGFR (HER-1) and HER-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lapatinib: adverse effects

A
  • QT prolongation
  • increased diarrhea
  • hepatotoxicity
  • rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Erlotinib: what it targets

A
  • EGFR-tyrosine kinase inhibitor that blocks signal transduction pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Erlotinib: adverse effects

A
  • Rash

- Diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Trastuzumab: what it targets

A
  • Binds to HER-2

- Used for metastatic breast CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Trastuzumab: adverse effects

A
  • *Black box warning
  • Cardiac failure
  • Do not give with anthracene derivatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Panitumumab: what it targets

A
  • EGFR ligand (binds to HER-1 receptor)

- Used for metastatic colon CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Panitumab: adverse effects

A

Same as cetuximab

  • fatigue
  • GI complaints
  • Abd. pain
  • sudden death/ cardiopulmonary arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cetuximab: what it targets

A
  • Binds specifically to EGFR (HER-1)

- Used for metastatic colorectal CA, neck and head CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cetuximab: adverse effects

A
  • fatigue
  • GI complaints
  • Abd. pain
  • Rarely sudden cardiac death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alemtuzumab: what it targets

A
  • Directed against CD52

- Used for Bcell chronic lymphocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alemtuzumab: adverse side effects

A
  • *Black Box Warning
  • opportunistic infections
  • severe infusion related reactions
  • hematologic toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ibritumomab/ Tositumomub: what it targets

A
  • Binds to CD20

- Used for relapsed/refractory low grade follicular or transformed Bcell non-hodgkin lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ibritumomab/Tositumomub: adverse effects

A
  • severe infusion related rxns (anaphylaxis)
  • Thrombocytopenia
  • Neutropenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Rituximab: what it targets

A
  • Binds to CD20

- Used for Non-hodgkins lymphoma and CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Rituximab: adverse effects

A

From the infusion related complex:

  • fever
  • chills
  • nausea
  • asthenia
  • headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vorinostat: what it does

A
  • Histone deacetylase inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vorinostat: adverse effects

A
  • PE/DVT

- Dose related thrombocytopenia and anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Arsenic Trioxide: what it does

A

Helps with:

  • inducing the growth progression of cancerous cells into mature normal cells
  • induces apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Asparaginase: what it does

A

Enzyme which degrades L-asparagine and decreases its supply and also inhibits protein synthesis (leukemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hydroxyurea: what it does

A

Inhibits ribonucleotide reductase. (inhibits DNA synthesis)

Used for sickle cell anemia and to lower patients WBC count before chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hydroxyurea: adverse effects

A

At higher doses:

  • clastogenicity
  • mutagenicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Bleomycin: what it does

A

Anti-tumor, antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Bleomycin: adverse effects

A
  • Pulmonary fibrosis

- Skin and Lung toxicities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Cisplatin/carboplatin/oxaliplatin: what they do

A

Kill cells by intercalating with the DNA

30
Q

Cisplatin: adverse effects

A
  • nephrotoxicity
  • ototoxicity
  • peripheral neuropathy
  • emesis
  • anemia
31
Q

Carboplatin: adverse effects

A
  • hematologic toxicity
  • renal damage
  • peripheral neuropathy
  • ototoxicity
  • N/V
    (not as bad as cisplatin)
32
Q

Oxaliplatin: adverse effects

A
  • moderate emesis
  • peripheral neuropathy
  • cold induced neuropathies
  • NOT nephrotoxic or ototoxic
33
Q

Carmustine (or BCNU)/ Lomustine (CCNU): what it does

A

Direct application to residual tumor tissue following surgical resection of brain tumors (IV or wafer)

34
Q

Bendamustine: what it does

A

Active against “quiet” AND dividing cells (lymphoid cancers like CLL and non-hodgkins)

35
Q

Cyclophosphamide/ifosfamide: what they do

A

Used for solid tumors and hematologic cancers

36
Q

Cyclophosphamide: adverse affects

A

In high doses it can cause hemorrhagic cystitis

37
Q

Ifosfamine: adverse affects

A
  • hemorrhagic cystitis
  • encephalopathy
  • CNS toxicity
38
Q

Mitoxantrone: what it does

A

Intercalating topoisomerase II inhibitor. Used in MS patients

39
Q

Mitoxantrone: adverse effects

A
  • Cardiotoxicity

- AML

40
Q

Doxorubicin/Daunorubicin/Idarubicin/Epirubicin: what it does

A

Intercalating topoisomerase inhibitors (insert or stack between base pairs in the DNA)

41
Q

Doxorubicin/Daunorubicin/Idarubicin/Epirubicin: adverse effects

A
  • AML
  • Ftal CHF in doses>400 (doxo)
  • *Administer Totect within a 6 hour window if the pt is at risk for these symptoms
42
Q

Etoposide/Teniposide: what they do

A

Damage tumor cells by causing strand breakage through inhibition of topoisomerase II

43
Q

Etoposide/Teniposide: adverse effects

A
  • Severe myelosupression with
  • infection or
  • bleeding
44
Q

Topotecan/Irinotecan: what they do

A

Through SN-38 (active metabolite) they inhibit topoisomerase I enzyme activity

45
Q

Topotecan/Irinotecan: adverse effects

A

Higher risk of diarrhea and neutropenia (can treat diarrhea with loperamide)

46
Q

Estramustine: what it does

A

Binds to microtubule associated proteins that are part of the structural support for microtubules. Binding causes the separation of the microtubules causing disassembly.(inhibit assembly)

47
Q

Epothilone/Ixabepilone: what it does

A

Binds to microtubules so they can not disassemble. Cannot pull the microtubules apart

48
Q

Epothilone/Ixabepilone: adverse effects

A

Similar to taxanes

49
Q

Paclitaxel/Docetaxel: what it does

A

Promotes microtubule assembly and therefore interfere with microtubule disassembly (prevent disassembly from happening)

50
Q

Paclitaxel: adverse effects

A
  • Myelosupression
  • increased neurotoxicity
  • hypersensitive reactions
  • premedicate with corticosteroids and antihistamines to decrease allergic reactions
  • DO NOT give to pt with neutrophils<1500
  • Do not give for solid tumors
51
Q

Docetaxel: adverse effects

A
  • myelosuppression
  • increased fluid retention
  • premedicate with corticosteroids
  • DO NOT give to pt with bilirubin>ULN or SGOT/SGPT>1.5ULN
52
Q

Vinca Alkaloids: what they do

A

Mitotic inhibitors. Inhibits assembly of microtubules

53
Q

Vinca Alkaloids: adverse effects

A

Increased risk of extravasation (apply heat if this occurs)

54
Q

Antifolates: what they do

A

Inhibit dihydrofolate reductase which reduce dietary folates. (floats are needed for DNA synthesis)

55
Q

Antifolates: adverse effects

A
  • neutropenia
  • thrombocytopenia
  • mucositis
  • hepatotoxicity
  • N/V
  • renal tubular necrosis with methotrexate (vigorous hydration!!!!)
56
Q

Cladribine: what it does

A

Antitumor activity affects both actively dividing and resting cancer cells. Resists deactivation by adenosine deaminase

57
Q

Cladribine: adverse effects

A
  • myelosupression

- increased risk of opportunistic infection

58
Q

Pentostatin: what it does

A

Inhibits adenosine deaminase

59
Q

Pentostatin: adverse effects

A
  • Pulmonary toxicity if given with fludarabine

- Dose limiting severe renal, liver, pulmonary and CNS toxicities

60
Q

Fludarabine: what it does

A

Interferes with DNA polymerase, causing chain termination

61
Q

Fludarabine: adverse effects

A

Dose limiting toxicity:

  • myelosupression
  • increased risk of opportunistic infection
62
Q

Mercaptopurine/Thioguanine: what they do

A

Converted to ribonucleotides that inhibit purine biosynthesis. (TPMT)

63
Q

Mercaptopurine/ Thioguanine: adverse effects

A
  • hepatic toxicity
  • myelosuppression
  • Mercaptopurine metabolism is decreased by xanthine oxidase inhibitor (allopurinol). Make sure you reduce it by 75% when administered together and monitor
64
Q

Azacytidine/Decitabine: what they do

A
  • Slows progression of myelodisplastic syndrome to AML

- Reduce tranfusion requirements an allows for normal hematopoiesis

65
Q

Azacytidine/Decitabine: adverse effects

A

Myelosuppresion

66
Q

Gemcitabine: what it does

A

Inhibits DNA polymerase activity and ribonucleotide reductase

67
Q

Cytarabine: what it does

A

Phosphorylated to its active form within tumor cells which inhibit DNA polymerase (responsible for strand elongation)

68
Q

Cytarabine: adverse effects

A

Dose dependent

  • cerebellar syndrome of dysarthria, nystagmus and ataxia
  • bone suppression w/ leukopenia, thrombocytopenia and anemia
  • N/V
  • and. pain
  • oral ulceration
  • hepatic dysfunction
69
Q

Capecitabine: what it does

A

Orally active pyrimidine analog of uracil and is a prodrug of 5-FU

70
Q

Capecitabine: adverse effects

A
  • *Black box warning: monitor INR if pt is on coumadin. Increased risk of bleeding!
  • neutropenia
  • thrombocytopenia
  • anemia
  • Hand-foot syndrome
  • diarrhea
71
Q

5-Fluorouracil: what it does

A

Phosphorylated to fluorodeoxyuridine monophosphate which binds tightly and interferes with the function of THYMIDYLATE SYNTHESIS which is required for synthesis of thymidine

Pharm Fall (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions